Abbvie (ABBV) PT raised to $250 at Cantor Fitzgerald on Skyrizi, Vyalev gains
Tweet Send to a Friend
Cantor Fitzgerald analyst Carter Gould raised the price target on Abbvie (NYSE: ABBV) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
